Sign Up Today and Learn More About Curevo Stock
Invest in or calculate the value of your shares in Curevo or other pre-IPO companies through EquityZen's platform.
Curevo Stock (CUR)
Curevo is a clinical-stage biotech firm that focuses on producing vaccines.
About Curevo Stock
Founded
2018
Headquarters
Bothell, WA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Curevo Press Mentions
Stay in the know about the latest news on Curevo
The Naming Patterns Behind 12,000 Biotech Companies
labiotech • Jun 19, 2026
Eli Lilly continues dealmaking roll with $1bn AlzeCure agreement
pharmaceutical-technology • Jun 11, 2026
Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy?
fool • Jun 09, 2026
Top biotech deals in May 2026
labiotech • Jun 08, 2026
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing
fool • Jun 06, 2026
Curevo Management
Leadership team at Curevo
CEO
George Simeon
Chief Medical Officer
Guy De La Rosa
Join now and verify your accreditation status to gain access to:
- Curevo Current Valuation
- Curevo Stock Price
- Curevo Management
- Available deals in Curevo and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Curevo Cap Table and Funding History by Share Class and Liquidity Preferences
- Curevo Revenue and Financials
- Curevo Highlights
- Curevo Business Model
- Curevo Risk Factors
- Curevo Research Report from SACRA Research
Trading Curevo Stock
How to invest in Curevo stock?
Accredited investors can buy pre-IPO stock in companies like Curevo through EquityZen funds. These investments are made available by existing Curevo shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Curevo stock?
Shareholders can sell their Curevo stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
